-
Pharmacogene Variation Consortium (abbreviated as PhamVar) is an
international group of
experts that
maintains a
systematic nomenclature system for allelic...
- is
within a Very
Important Pharmacogene (VIP) as
defined by PharmGKB. The
variants in
level 2A are in
known pharmacogenes, so
functional significance...
-
Miller NA,
Leeder JS, Whirl-Carrillo M,
Klein TE (March 2018). "The
Pharmacogene Variation (PharmVar) Consortium:
Incorporation of the
Human Cytochrome...
-
Klein TE,
Altman RB (March 2014). "PharmGKB summary: very
important pharmacogene information for UGT1A1".
Pharmacogenet Genomics. 24 (3): 177–83. doi:10...
- care.
pharmacogenetics pharmacogenomics pharmacokinetics pharmacodynamics PharmGKB Pharmacogene Variation Consortium "CPIC".
Retrieved 2022-03-29. v t e...
-
Johnson JA,
Hebert JM,
Altman RB, et al. (June 2010). "Very
important pharmacogene summary:
thiopurine S-methyltransferase".
Pharmacogenetics and Genomics...
-
process that
relies on the "star"
nomenclature system maintained by the
Pharmacogene Variation Consortium ****igns
labels to
known polymorphisms that affect...
-
Johnson JA,
Hebert JM,
Altman RB, et al. (June 2010). "Very
important pharmacogene summary:
thiopurine S-methyltransferase".
Pharmacogenetics and Genomics...
-
Implementation Consortium (CPIC). The
label CYP2C9*1 is ****igned by the
Pharmacogene Variation Consortium (PharmVar) to the most
commonly observed human gene...
-
Johnson JA,
Hebert JM,
Altman RB,
Klein TE (June 2010). "Very
important pharmacogene summary:
thiopurine S-methyltransferase".
Pharmacogenetics and Genomics...
